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To the Editor,
We read with great pleasure the correspondence from
Dr Huang regarding our article “Hepatitis C treatment
outcome in relation to alcohol consumption and racial
differences in southeastern Taiwan.”1 Dr Huang strongly
agreed that the major contributing factor to the response
rate of interferon therapy is compliance among drinkers;
for this reason, we employed a reference nurse to make
regular visits to raise the sustained virological response
rate. Concerning the relationship between drinking and
Aboriginal people, we found that there was no significant
difference in drinking between Aboriginal (59.2%) and
non-Aboriginal (58.2%) patients. With regards to the
treatment impact factors for drinking and Aboriginal
people, the odds ratios were about 0.98 for drinkers andTable 1 The common side effects between drinkers or not in naı¨
ribavirin.
Overall (%) Drinker (
Alopecia 16.5 20 (14.9
Abdominal pain 23.4 27 (20.1
Loss of appetite 48.4 63 (47.0
Myalgia 56.4 74 (55.2
Dizziness 56.9 75 (56.0
Headache 44.7 63 (47.0
Insomnia 54.3 69 (51.9
Feeling nervous 18.6 26 (19.4
Fatigue 63.3 84 (62.7
Fever 41.0 57 (42.5
Influenza-like illness 19.1 25 (18.7
Depression 21.8 31 (23.1
Palpitation 25.5 32 (23.9
Chest discomfort 24.5 34 (25.4
Data are presented as n (%), unless otherwise indicated.
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The author also provided data regarding the adverse
events associated with pegylated interferon and ribavirin
therapy in patients with chronic hepatitis C. These data
showed that depression developed early in the course of
therapy.2 We agree with Dr Huang that the multidisciplinary
approach should be started early, even before the treat-
ment is initiated. We did not focus on the adverse effects,
but we retrospectively studied this issue and found that
some of the common side effects were more frequent than
previously reported in the literature. These events included
loss of appetite (48.4%), dizziness (56.9%), and insomnia
(54.3%), with no significant difference between drinkers
and nondrinkers (Table 1). Regarding the adverse events inve hepatitis C virus patients treated with peginterferon-a plus
n Z 134) Nondrinker (n Z 54) p
) 11 (20.4) 0.363
) 17 (31.5) 0.097
) 28 (51.9) 0.548
) 32 (59.3) 0.614
) 32 (59.3) 0.680
) 21 (38.9) 0.311
) 33 (61.1) 0.231
) 9 (16.7) 0.663
) 35 (64.8) 0.784
) 20 (37.0) 0.488
) 11 (20.4) 0.787
) 10 (18.5) 0.488
) 16 (29.6) 0.413
) 12 (22.2) 0.649
ant to this article.
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Table 2 The common side effects between different races in naı¨ve hepatitis C virus patients treated with peginterferon-a plus
ribavirin.
Aboriginal (n Z 44) Non-Aboriginal (n Z 144) p
Alopecia 2 (4.5) 29 (20.1) 0.018
Abdominal pain 11 (25.0) 33 (22.9) 0.775
Loss of appetite 19 (43.2) 72 (50.0) 0.428
Myalgia 21 (47.7) 85 (59.0) 0.186
Dizziness 26 (59.0) 81 (56.3) 0.739
Headache 18 (40.9) 66 (45.8) 0.565
Insomnia 17 (38.6) 85 (59.0) 0.017
Feeling nervous 7 (15.9) 28 (19.4) 0.598
Fatigue 28 (63.6) 91 (63.2) 0.959
Fever 16 (36.4) 61 (42.4) 0.479
Influenza-like illness 6 (13.6) 30 (20.8) 0.288
Depression 7 (15.9) 34 (23.6) 0.279
Palpitation 12 (27.2) 36 (25.0) 0.762
Chest discomfort 12 (27.2) 34 (23.6) 0.621
Data are presented as n (%).
1102 Letter to the Editordifferent races, there were significant differences in the
frequencies of alopecia and insomnia between aboriginal
and non-Aboriginal people (Table 2).
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